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Leber congenital amaurosis (LCA) is an inherited
retinal dystrophy that causes childhood blindness.
Photoreceptors are especially sensitive to an intronic
mutation in the cilia-related gene CEP290, which
causes missplicing and premature termination, but
the basis of this sensitivity is unclear. Here, we gener-
ated differentiated photoreceptors in three-dimen-
sional optic cups and retinal pigment epithelium
(RPE) from iPSCs with this common CEP290 muta-
tion to investigate disease mechanisms and evaluate
candidate therapies. iPSCs differentiated normally
into RPE and optic cups, despite abnormal CEP290
splicing and cilia defects. The highest levels of aber-
rant splicing and cilia defects were observed in optic
cups, explaining the retinal-specific manifestation
of this CEP290 mutation. Treating optic cups with
an antisense morpholino effectively blocked aber-
rant splicing and restored expression of full-length
CEP290, restoring normal cilia-based protein traf-
ficking. These results provide a mechanistic un-
derstanding of the retina-specific phenotypes in
CEP290 LCA patients and potential strategies for
therapeutic intervention.
INTRODUCTION
Primary cilia are sensory organelles that project from the cell
surface in most eukaryotic cells and affect signaling cascades
in response to environmental stimuli. Photoreceptors use a high-
ly specialized sensory cilium, the ‘‘outer segment’’ (OS), which
contains tightly stacked discs containing the photopigment
opsin, to detect light. Degeneration of photoreceptors is a major
cause of blindness, and Leber congenital amaurosis (LCA) is a
recessively inherited form of retinal dystrophy resulting in severeCell Stem Cell 18, 769–781
This is an open access article undvisual loss in early childhood (Koenekoop, 2004). LCA affects
between 1:30,000 to 1:81,000 individuals and accounts for 5%
of all inherited retinal dystrophies (Koenekoop, 2004). One of
themost common causative LCA genes isCEP290 (centrosomal
protein of 290 kDa; OMIM: 611755), accounting for around 15%–
25% of cases (Chacon-Camacho and Zenteno, 2015; den Hol-
lander et al., 2006, 2008).
CEP290 (also known as LCA10, BBS14, JBTS5, NPHP6,
MKS4, and SLSN6) is a 92 kb gene of 55 exons, encoding a
2479 amino acid 290 kDa protein originally described as a
component of the centrosome (Andersen et al., 2003). During
mitosis, CEP290 is found at the centrosome (Sayer et al.,
2006), while in an interphase cell, CEP290 is located on both
mother and daughter centrioles (Tsang et al., 2008). In photore-
ceptors, CEP290 is located in the connecting cilium (Sayer et al.,
2006). During ciliogenesis, CEP290 is found at the distal end
of the mother centriole that becomes part of the basal body at
the base of the cilium, suggesting a role for CEP290 in cilium
assembly (Chang et al., 2006; Tsang et al., 2008). Indeed, there
is growing and compelling evidence for a critical function of
CEP290 in ciliogenesis, as multiple studies have shown that
loss of CEP290 reduces ciliogenesis (Kim et al., 2008; Sang
et al., 2011; Tsang et al., 2008), without affecting cell-cycle pro-
gression. CEP290 forms a complex with CP110, another centro-
somal protein, which leads to CEP290 inactivation until the
cell enters quiescence, whereupon the CP110:CEP290 complex
dissociates and CEP290 recruits Rab8a, a small GTPase, and
triggers ciliogenesis (Tsang et al., 2008).
Mutations inCEP290 are associatedwith numerous syndromic
ciliopathies such as Joubert syndrome (JBTS), nephronophthisis
(NPHP),Meckel-Gruber syndrome (MKS), andSenior-Lokensyn-
drome (SLSN) (Coppieters et al., 2010). The severity of the dis-
ease and number of affected organs have been suggested to
be related to the amount of residual CEP290 function (Drivas
et al., 2015). A recent meta-analysis of 138 CEP290 mutations
in 250 individuals demonstrated that LCA is the most common
associated phenotype (57%) and that 86% of the CEP290 LCA
patients had at least one copy of themost commonCEP290mu-
tation, a deep intronic c.2991+1665A>G change (Drivas et al.,, June 2, 2016 ª 2016 The Authors. Published by Elsevier Inc. 769
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
2015). This mutation in intron 26 results in aberrant splicing and
subsequent inclusionof a 128basepair (bp) cryptic exoncontain-
ing an immediate premature stop codon (p.C998X) between
exons 26 and 27. This mutation is specifically associated with
LCA retinal dystrophy, and not syndromic disease (denHollander
et al., 2006; Drivas et al., 2015). Importantly, a residual fraction of
full-length CEP290mRNA is still spliced correctly and translated
to full-length CEP290 protein. This residual CEP290 protein
expression was reported to be as high as 50% of control levels
in CEP290-LCA fibroblasts and has been suggested to account
for the retinal-only phenotype seen in these individuals, with the
remaining protein being sufficient to enable cilia function in other
organs (den Hollander et al., 2006; Drivas et al., 2015). It is not
clear, however, why photoreceptors would be more vulnerable
to reduced CEP290 levels than other cells.
Therapeutic options for retinal dystrophies such as LCA are
limited. A promising therapeutic strategy in LCA associated
with the deep intronic mutation in CEP290 is to target the aber-
rant splicing using antisense oligonucleotides (AONs). AONs are
short, modified RNA molecules that can interfere with splicing,
either to adjust levels of naturally occurring splice isoforms or
to induce exon skipping of protein-truncating cryptic exons.
AONs have been used in CEP290-LCA fibroblasts to provide
proof-of-principle that aberrant CEP290 splicing can be cor-
rected, and the ciliation defect of affected cells can be restored
(Collin et al., 2012; Gerard et al., 2012).
Induced pluripotent stem cells (iPSCs) are a potent technology
that allows for directed differentiation toward most cell types,
including retinal cell types. Using this technology with cells
derived from affected patients is a powerful technique to model
disease. Importantly, this provides an appropriate cellular model
with the genetic mutation(s) in genomic context. We have
recently used iPSC-derived retinal pigment epithelium (RPE)
cells from an individual with RP2 X-linked retinitis pigmentosa
to test the potential of translational readthrough-inducing drugs
to bypass a stop codon and produce functional protein (Schwarz
et al., 2015). Advances in iPSC-photoreceptor differentiation
techniques have provided a platform for investigating the effects
of patient mutations on neural retinal development and mainte-
nance (Nakano et al., 2012; Zhong et al., 2014). In this study,
we used fibroblasts from an individual with LCA caused by a
homozygous c.2991+1655A>Gmutation to create iPSC-derived
RPE and three-dimensional (3D) optic cups. These cell types
were used to probe disease mechanisms and test antisense
morpholino (MO) efficacy on CEP290 aberrant splicing. The
data reveal a potential explanation for the retinal specificity asso-
ciated with this mutation and proof of concept that AON therapy
is effective in photoreceptors.
RESULTS
LCA Fibroblasts Express Misspliced CEP290 and Have
Impaired Ciliogenesis
Fibroblasts were derived from a dermal skin biopsy of a 39-year-
oldmalewhowas diagnosedwith LCA as a child. The patient was
homozygous for the c.2991+1665A>G change and had no signs
of syndromic disease. He had no detectable ERG, and retinal im-
aging showed attenuated vessels, peripheral RPE atrophy, and
mottling, with a centrally preserved outer nuclear layer and inner770 Cell Stem Cell 18, 769–781, June 2, 2016segment ellipsoid band on spectral-domain OCT scanning that
corresponded to the increased hyperautofluorescent ring in the
macula on autofluorescence imaging (FigureS1, available online).
In control fibroblasts, CEP290 protein was present at the
base of the acetylated a-tubulin-positive cilium, as previously
described (Chang et al., 2006; Valente et al., 2006). In contrast,
CEP290 localization at the base of cilia was severely reduced
in LCA fibroblasts (Figure 1A; arrowheads). RT-PCR analysis
of LCA fibroblasts using primers spanning exons 26 and 27 of
the CEP290 gene revealed the presence of incorrectly spliced
transcript containing the cryptic exon (26-X-27), in addition to
the normal transcript (26-27) observed in controls (Figure 1B).
Primers specific to the cryptic exon amplified a product in LCA
fibroblasts only (Figure 1B). Incorrectly spliced transcript (26-X-
27) represented the majority (60%) of total CEP290 mRNA in
LCA cells. Immunoblotting confirmed that CEP290 missplicing
leads to reduced levels of CEP290 protein compared to control
fibroblasts (Figure 1C). CEP290 is known to play a critical role
in the process of ciliogenesis, and cilia incidence was signifi-
cantly reduced in LCA fibroblasts (Figures 1D and 1E) and
the cilia present were significantly shorter (Figure 1F). Thus, we
were able to detect and measure functional defects in ciliogene-
sis in CEP290-LCA patient cells.
LCA-iPSC-RPE Exhibit Relatively Mild CEP290 Aberrant
Splicing and Impaired Ciliogenesis
CEP290-LCA and control fibroblasts were reprogrammed to
iPSCs by electroporation with episomal vectors containing the
four Yamanaka factors (Oct4, Sox2, Klf4, and Myc), Lin28, and
a short hairpin RNA (shRNA) to p53 (Okita et al., 2011; Schwarz
et al., 2015). Emerging iPSC colonies were isolated, expanded,
and clonally selected to generate clonal lines 1 and 2 (Figures
S2A–S2C). The cells formed round, tightly compacted colonies
that were positive for iPSC markers (Figures S2D and S2E).
The pluripotent status of the CEP290-LCA lines was confirmed
by comparing gene expression at the iPSC stage and following
undirected embryoid body (EB) differentiation to that of 12 em-
bryonic and 12 iPSC reference lines using the Taqman hPSC
Scorecard panel (Figures S2F and S2G) as previously described
(Tsankov et al., 2015). CEP290 was present at the base of cilia
in control iPSCs, but not in LCA iPSCs in which aberrant splicing
of the cryptic exon 26-X-27 was detected (Figures S3A and
S3B). Cilia incidence was significantly reduced in LCA iPSCs
compared to control iPSCs, although the length of the remaining
cilia was similar (Figures S3C–S3E).
Clonally derived iPSC lines were differentiated into RPE cells
by growing them to confluence and withdrawing bFGF as
described previously (Carr et al., 2009; Schwarz et al., 2015; Vu-
gler et al., 2008). TheCEP290mutation did not appear to delay or
reduce the efficiency of the differentiation process, and pig-
mented colonies of RPE appeared at around week 4 in both
LCAandcontrol cell lines.Clusters ofRPEwere isolatedmanually
after 8 weeks. Control and CEP290-LCA lines formed pigmented
monolayers ofRPEwith typical polygonalmorphology (Figure 2A)
and were immunopositive for an array of RPE markers (Figures
2B–2E). Analysis of monolayer sections revealed polarized cells
expressingMerTK apically and collagen IV in the basal layer (Fig-
ures 2D and 2E). RT-PCR confirmed the expression of the cryptic
exon in LCA iPSC-RPE (Figure 2F). Interestingly, the ratio of the
Figure 1. CEP290-LCA Fibroblasts Have Reduced CEP290 Levels and Ciliation
(A) CEP290 (green) localization at the base of the cilia (arrow and arrowheads). Acetylated a-tubulin (Ac. tubulin; red) was used to mark the ciliary axoneme. Scale
bar, 10 mm.
(B) RT-PCR analysis of control and LCA cDNA using primers to exons 26 and 27, and the cryptic exon (Exon X), ofCEP290 revealed two bands in the LCA samples
representing correct wild-type (WT) transcript (Exon 26-27) and a higher molecular weight band, including the cryptic exon (Exon 26-X-27), compared to the WT
band alone in control. Relative quantification of band intensity is shown underneath. Values are mean ± 2 3 SEM. n = 3.
(C) Western blot showed a reduction in full-length wild-type CEP290 protein in LCA fibroblasts compared to controls. Quantification of band intensity relative to
actin is shown underneath.
(D) Representative images of cilia using cilia markers Arl13 (red), to mark the axoneme, and pericentrin (PCN; green), to mark the basal body, in control and LCA
fibroblasts. Cilia appear shorter in LCA cells compared to controls (zoom panels). Scale bar, 10 mm.
(E and F) Quantification of (E) ciliation of cells and (F) cilia length. Values are mean ± 23 SEM. n = 3 biological replicates of at least 65 cells per replicate. Statistical
significance was determined using Student’s t test, *p < 0.05. See also Figure S1.correctly spliced (26-27) to misspliced (26-X-27) transcript
differed in the LCA RPE compared to LCA fibroblasts with the
aberrant misspliced transcript accounting for only 50% of the
total (Figure 2G). We examined the effect of CEP290missplicing
onRPEcilia incidence and length andobserved a slight reduction
in LCA RPE cells compared to control (Figures 2H–2J).
Differentiation of iPSCs to Opsin-Expressing
Photoreceptors
Photoreceptors are highly polar neurons with a distinctive inner
and outer segment joined by a connecting cilium where
CEP290 is thought to play an important role in protein trafficking.
In order to study the effects of CEP290 depletion on photore-
ceptor genesis and maintenance, LCA and control iPSCs were
differentiated using the 3D techniques for ‘‘optic cup’’ differenti-
ation pioneered by Nakano et al. (Nakano et al., 2012). The
progress of their differentiation was monitored by immunofluo-
rescence and RT-PCR (Figure 3).After 3–5 weeks of EB culture in retinal-cell-inducing medium,
pouches of transparent neuroepithelium could be seen emerging
from the embryoid bodies in both LCA and control cell lines.
These pouches were dissected out and subcultured in retinal
cell maturation media. After 2–3 further weeks in suspension
culture, the pouches formed spherical aggregates with a thick,
transparent mantel and histological features of an embryonic
retina, including a Brn3/HuD-positive ganglion cell layer, a
Chx10/Pax6-positive neuroblastic layer (Figure S4A), and occa-
sional cone-arrestin- and recoverin-positive cells (Figure S4B).
In the next stage of temporal development, the optic cups
developed a more defined outer nuclear layer (ONL) containing
migrating recoverin-positive progenitors (Figures 3B and S4B),
as well as cone-arrestin-positive cells (Figure S4B), but no opsin
expression (Figure S4C). As in normal development, the differen-
tiation and organization of iPSCs into a polarized and stratified
neuroepithelium was concomitant with polarization of the cilia
at the apical layer of both control and LCA optic cups (Figure 3B).Cell Stem Cell 18, 769–781, June 2, 2016 771
Figure 2. CEP290-LCA iPSC-RPE Generation
(A–E) (A) Control and LCA RPE cells showed pigmentation and typical ‘‘cobblestone’’ appearance and expressed RPE-specific markers (B) ZO1 (green), MitF
(red), (C) CRALBP (green), OTX2 (red), (D) MerTK (green), (E) Col4 (green), and Pmel17 (red). Scale bar, 20 mm.
(F and G) LCA RPE cells showed expression of cryptic exon via RT-PCR analysis of CEP290 exons 26-27 and exon X. Values are mean ± 2 3 SEM. n = 3
(H) Representative immunostaining of cilia using cilia markers Arl13 (red), to mark the axoneme, and pericentrin (PCN; green), to mark the basal body, in control
and LCA RPE. Scale bar, 20 mm.
(I and J) LCA RPE had decreased ciliation and cilia length, compared to controls. Values are mean ± 2 3 SEM. n = 3 replicates of 50–100 cells. Statistical
significance was determined using Student’s t test, n.s. = not significant. See also Figures S2 and S3.Electron microscopy (EM) showed apical tight junctions (arrow
heads) and cilia (*) emerging amongmitochondria-rich inner seg-
ments (IS; Figures 3B and 3C).
At the latest time point investigated (week 21), EM analysis of
control optic cups revealed thepresenceofmultiple cilia and inner
segments that had become elongated. The majority of the pro-
truding cilia were broken at the distal tip, likely as a result of EM
processing; however, occasionally disorganized but intact outer
segments were observed elaborating from the connecting cilium
(Figure 3C). Recoverin (rod, cone, and bipolar cells)- and cone-
arrestin (cone specific)-positive cells were abundant across the
apical layer of LCA and control optic cups (Figures 3D, 3E, and
S4D). Rhodopsin-positive rod cells were detected across an
ONL approximately five cell nuclei deep with the most intense
staining seen in structures above the ONL (Figures 3D and 3E).
L/M- and S-opsin-positive cone cells were also detected in LCA
and control optic cups, but were less abundant than rods (Figures
3E and S4C). RT-PCR analysis of different developmental stages
revealedconcurrent expressionof earlydifferentiationgenessuch
as PAX6 and VSX2/CHX10, with similar parallel expression of
cone-rod (CRX) and rod-specific genes (NRL, NR2E3) in both
control and LCA optic cups (Figure 3F).772 Cell Stem Cell 18, 769–781, June 2, 2016LCA Optic Cups Have Severe CEP290Missplicing and
Associated Ciliation Defects
In control optic cup photoreceptors, CEP290 colocalized with
pericentrin at the base of the connecting cilia, whereas in LCA
optic cups, CEP290 was not detectable at the connecting cilia
(Figures 4A and S5A). RT-PCR confirmed the presence of the
cryptic exon in LCA optic cups (Figures 4B and S5A). Strikingly,
very little correctly spliced CEP290 transcript was expressed in
LCA optic cups (10%–20% of total CEP290 mRNA), whereas
in LCA fibroblasts and RPE, it was 40% and 50%, respectively
(Figures 1B, 2F, and 4B). Ciliation in developing optic cups was
examined in LCA and control cells. Prior to neuroepithelial diff-
erentiation, cilia were randomly dispersed in the center of the
embryoid bodies. As the EBs underwent neuroepithelial differen-
tiation, extensive migration and polarization of cilia to the apical
surface occurred in both control and LCA optic cups (Figures 4C
and S5C). Quantification of ciliated basal bodies in developing
optic cups revealed an increase in ciliogenesis with time and
a significant reduction in cilia incidence in the LCA cells at
all stages of optic cup development (Figures 4D and S5D).
Cilia length was significantly reduced at the latest time point
only, correlating with the very low levels of full-length CEP290
transcript (Figures 4E, 4F, and S5E). The missplicing of CEP290
was examined via RT-PCR during the differentiation period of the
optic cups (Figure 4F). At week 3 the splicing of CEP290 was
broadly similar to that seen in LCA fibroblasts, iPSCs, and
RPE. During subsequent development, the amount of 26-X-27
increased and 26-27 decreased. This correlated with expression
of retina-specific isoforms of BBS8 (Murphy et al., 2015) and
RPGR (Kirschner et al., 1999) (Figure 4F), suggesting that
increased missplicing of CEP290 is associated with photore-
ceptor differentiation and the inclusion of photoreceptor-specific
exons.
Antisense Morpholino Treatment Reduces Aberrant
Splicing and Restores Ciliogenesis in CEP290-LCA RPE
and Photoreceptors
AONs designed to target the aberrant splice donor site in
CEP290 have been shown to increase the relative proportion
of correctly spliced CEP290 and restore ciliation in LCA fibro-
blasts (Collin et al., 2012; Gerard et al., 2012). Assessing the
effect of AONs on CEP290-LCA RPE and photoreceptors pro-
vides a unique opportunity to assess their therapeutic efficacy
in the tissue that manifests LCA disease pathology. A 25 bp
antisense morpholino (CEP290-MO) was developed against
the c.2991+1665A>G change in CEP290 and tested on LCA
fibroblasts alongside a standard control-MO (Figure S6). RT-
PCR revealed that an increase in CEP290 26-27 transcript
and concurrent reduction in cryptic exon inclusion occurred af-
ter 48 hr at doses of 10 mM and above (Figure S6A). At 10 mM,
levels of correctly spliced CEP290 mRNA increased by 25%,
compared to control-MO (Figures 5A and S6D). MO treatment
was still effective 9 days after CEP290-MO treatment and
increased the levels of correctly spliced product to over 80%
of the total transcript (Figure S6E). Control and LCA RPE
were treated with control- or CEP290-MO once every 7 days
for 14 days. Similar to the LCA fibroblasts, the treatment led
to an increase in correctly spliced transcript in RPE cells, but
the relative increase was reduced compared to fibroblasts
(15%), probably because of the higher steady-state levels of
the correctly spliced exon 26-27 transcript in LCA RPE cells
(Figure 5B).
Depletion of CEP290 has been reported to affect photo-
receptor viability soon after photoreceptor differentiation
(Chang et al., 2006). Therefore, we treated LCA optic cups
at week 13, a point in their temporal development when recov-
erin- and cone-arrestin-positive photoreceptor progenitors were
observed and aberrant 26-X-27 splicing was high. At this time
point, ciliation was significantly reduced in LCA optic cups rela-
tive to controls, but full photoreceptor differentiation had not
occurred (Figures S4B, 4C, and 4D). Optic cups were treated
with control- or CEP290-MO every 3–4 days for 4 weeks. Unlike
RPE and fibroblasts, the 3D optic cups comprise several cell
layers tightly packed together (Figures 3D and S4). In order to
assess the ability of the MO to penetrate the optic cups, the
localization of a fluorescein-tagged control-MO was determined
using live cell confocal microscopy. Both punctate and
dispersed fluorescein could be observed throughout all cell
layers 48 hr posttreatment (Figure S4E). CEP290-MO-treated
LCA optic cups had significantly increased levels of the correctly
spliced exon 26-27 transcript, increasing to over 50% of thetotal transcript in LCA line 1 (Figure 5C) and up to 70% in LCA
line 2 (Figures S7A and S7B). This increase was considerably
higher than the CEP290-MO-induced changes observed in
fibroblasts and RPE cells, implying that the MO therapy for
CEP290 is particularly potent in photoreceptors, most likely
because of the higher basal level of aberrant splicing observed
in these cells.
CEP290-MO treatment also had a functional impact on cilia-
tion levels, as measured by incidence of Arl13 staining, in all
cell types investigated. In LCA fibroblasts, cilia incidence was
significantly increased, but cilia length remained similar (Figures
5D–5F). In LCA RPE cells (Figures 5G–5I), both cilia incidence
and length were increased, but only the increase in length
reached statistical significance. In LCA optic cups, CEP290-
MO treatment significantly increased both the number and
length of cilia emerging from recoverin- and cone-arrestin-posi-
tive photoreceptor progenitors, in both cell lines (Figures 5J–5L
and S7C–S7E).
CEP290-MO Therapy Restores Defective Cilia Protein
Traffic in LCA Fibroblasts and Optic Cups
The ability of CEP290-MO treatment to restore functional
CEP290 protein expression was investigated in LCA fibroblasts.
CEP290 was almost undetectable at the basal body by immuno-
fluorescence, whereas following CEP290-MO treatment it could
be detected at levels similar to control (Figures 6A and 6B).
Western blotting revealed an increase in CEP290 protein levels
(Figure 6C). To determine whether the restored protein level
had an effect on known CEP290-interacting proteins, we inves-
tigated the traffic of RPGR and Rab8 to cilia in LCA fibroblasts
treatedwith control- or CEP290-MO. In control-MO treated cells,
the ciliary targeting of RPGR and Rab8 was disrupted and both
proteins had impaired ciliary localization, compared to control fi-
broblasts (Figures 6D–6G). Importantly, the traffic of these pro-
teins to cilia was significantly rescued by CEP290-MO treatment
(Figures 6E and 6G).
We next investigated the ability of CEP290-MO to restore
CEP290 protein levels and ciliary localization of RPGR in optic
cups. CEP290-MO treatment significantly increased the number
of CEP290-positive cilia at the basal body and transition zone
(Figures 7A–7C, 7E, 7G, S7F, and S7G), as well as increasing
CEP290 protein levels detected by western blotting (Figure 7D).
In control optic cups, RPGR was detected by immunofluores-
cence at the ciliary transition zone, whereas in LCA optic cups
there was a significant reduction in detectable RPGR, indicating
that depletion of CEP290 reduces its ciliary localization in LCA
photoreceptor progenitors. Critically, CEP290-MO treatment
significantly rescued RPGR targeting to the cilium (Figures 7F
and 7H).
DISCUSSION
In this study, we have used LCA patient-derived cells to
examine the cellular consequences of reduction of CEP290
expression, particularly in the context of retinal cells, and tested
a potential therapy for alleviating the effect of reduced levels of
CEP290. We characterized fibroblasts, iPSCs, iPSC-derived
RPE, and optic cups from a patient homozygous for the com-
mon CEP290 c.2991+1665A>G mutation. We verified that allCell Stem Cell 18, 769–781, June 2, 2016 773
Figure 3. Generation of Opsin-Expressing Photoreceptors from iPSC Optic Cups following Long-Term 3D Suspension Culture
(A) Schematic of differentiation process from iPSCs to photoreceptor cells based on previously described method for the generation of optic cups from human
embryonic stem cells (Nakano et al., 2012).
(legend continued on next page)
774 Cell Stem Cell 18, 769–781, June 2, 2016
patient-derived cell types have reduced CEP290 expression, at
both mRNA and protein expression levels, compared to control
cells. The reduction in CEP290 expression in patient-derived
cells reduced ciliation. Importantly, full-length CEP290 is not
completely lost in patient-derived cells, suggesting residual
expression is sufficient for ciliogenesis to take place in the ma-
jority of ciliated tissues where CEP290 is expressed, with the
exception of the retina.
Mutations in CEP290 cause other partially overlapping, but
distinct, ciliopathies such as JBTS, MKS, NPHP, or SLSN. The
pleiotropicmanifestation ofCEP290 disease has eluded explana-
tion; recently, it has been suggested that itmaybea consequence
of the combination of mutation position and severity, with
exon skipping of some premature stop codons (Drivas et al.,
2015). Nevertheless, the observations of 40%–50% of full-length
CEP290 transcript andprotein inCEP290 c.2991+1665A>Gfibro-
blasts (den Hollander et al., 2006; Drivas et al., 2015) are hard to
reconcile with the absence of disease phenotype in carriers of
null alleles. Here, we provide direct evidence that tissue-specific
differences in splicing are also likely to contribute to the geno-
type:phenotype relationship. The CEP290 c.2991+1665A>G
allele is only associated with nonsyndromic retinal disease, and
our data suggest that this is likely to be a result of higher levels
of aberrant splicing in the human retina. Therefore, this intronic
change results in photoreceptors having a greater deficit of
CEP290 protein than other cells, leading to the disease affecting
thempreferentially, as opposed toa greater vulnerability of photo-
receptors to a similar reduction in CEP290 function.
The reasons for this different mRNA processing are currently
unclear, but it was recently shown that the human retina has
unexpectedly high levels of splicing diversity (Farkas et al.,
2013). Furthermore, the mutation of ubiquitously expressed
and highly conserved splicing factors PRPF6, PRPF8, and
PRPF31 causes retinal degeneration (Wright et al., 2010), sug-
gesting a specialized role of the splicing machinery in the
retina. Indeed, these splicing factors appear to be recruited
to the base of primary cilia and are involved in cilia function
(Wheway et al., 2015), suggesting a potential feedback loop
between cilia function and mRNA processing. Interestingly,
two naturally occurring animal models of CEP290 retinopathy,
the rd16 mouse and Abyssinian cat (Chang et al., 2006;
Menotti-Raymond et al., 2007), are also caused by different
aberrant splicing events, and a deep intronic mutation in
OFD1 results in partial cryptic exon missplicing and causes a
form of X-linked retinitis pigmentosa, as opposed to male
lethality caused by null alleles (Webb et al., 2012). The increase
in aberrant splicing in optic cups correlated with photore-
ceptor differentiation and the inclusion of photoreceptor-spe-
cific exons in other genes. Therefore, the retina appears to(B) In control optic cups, recoverin-positive cells formed an outer nuclear layer (ON
Scale bar, 20 mm.
(C) In control optic cups, electronmicrographs (EMs) at the apical surface show th
(arrowheads). Scale bar, 1 mm.
(D) In control optic cups, EM shows the elongation of inner segments (IS), conne
ciliary tip. Inserts show higher-power images of developing OS disk stacks. Sca
(E and F) Control (E) and CEP290-LCA (F) optic cups were immunopositive for rec
(right panels) at weeks 21 (E) and 17 (F). Scale bar, 20 mm (10 mm in zoom panel
(G) RT-PCR analysis of retinal development genes in control (Con) and CEP290-L
Figure S4.have a highly tuned RNA splicing machinery that potentially ex-
poses it to the risk of aberrant exon splicing more than other
tissues.
The availability of CEP290 model organisms, from Chlamydo-
monas to cat, has facilitated the understanding of CEP290 func-
tion (Chang et al., 2006; Craige et al., 2010; Menotti-Raymond
et al., 2007). CEP290 is known to be important in ciliogenesis
and the formation of the Y-shaped linkers that connect the
microtubule bundles to the membrane in the transition zone,
suggesting an important role of CEP290 at the ciliary gate,
which regulates intraflagellar transport components and entry
into the cilium (Craige et al., 2010; Reiter et al., 2012). We
have studied a range of human cells at a previously uninvesti-
gated level of detail. Our data show that reductions of CEP290
by 50%–60% result in detectable cilia defects; however, this
does not affect the ability of iPSCs to differentiate to a variety
of cell types, suggesting there is sufficient CEP290 to facilitate
a level of cilia function that is consistent with the signaling
involved in cell differentiation. This is consistent with the
retinal-only phenotype observed in CEP290-LCA patients.
Furthermore, within the retina cell types our data show that
the RPE are relatively unaffected, with relatively high levels of
wild-type CEP290 transcript. This confirms that the photorecep-
tors are the primary site of pathology, as observed in the rd16
mouse model.
Studies in human fibroblasts have suggestedAON therapymay
be able to combat CEP290-associated aberrant splicing (Collin
et al., 2012; Gerard et al., 2012); however, testing these potential
therapies in animals has not been possible because the mouse
and cat models have different causative mutations and the ther-
apy is sequence specific. An attempt to produce a humanized
mouse model of CEP290-LCA containing human exons 26 and
27, and intron 27 with or without the splicing mutation, resulted
in the creation of a separate cryptic exon, highlighting thedifficulty
in studying human splicing mutations in animal models (Garanto
et al., 2013). Therefore, modeling the disease in a human
sequence-specific context by studying iPSC-derived photore-
ceptors presents an ideal solution. CEP290-specific MO treat-
ment restored normal splicing and led to increased CEP290
protein production that was sufficient to rescue ciliation and
recruitment of Rab8 and RPGR to fibroblast cilia. Importantly,
CEP290-MO also increased CEP290 protein, restored ciliation,
andsignificantly improved the recruitment of the important photo-
receptor protein, RPGR, to the connecting cilia of photoreceptor
progenitor cells within optic cups. This clearly demonstrates sig-
nificant recovery of cilia traffic in LCA photoreceptors, which
may be critical to photoreceptor function and viability in vivo.
Optical coherence tomography (OCT) analysis has shown
that CEP290-LCA patients often retain central retina structureL) at week 13. Cilia (Arl13, red; PCN, green) were aligned at the apical surface.
e presence of cilia (*), mitochondria-rich inner segments (IS), and tight junctions
cting cilium (CC), and the presence of developing outer segments (OS) at the
le bar, 1 mm.
overin and cone arrestin (left panels), and rhodopsin and L/M and S cone opsin
).
CA fibroblasts (fibs) and optic cups at different times of development. See also
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Figure 4. CEP290-LCA Optic Cups Lack CEP290 Expression and Have Decreased Ciliation
(A) CEP290 (red) expression was absent from the basal body (pericentrin, PCN; green) in LCA optic cups at week 13, compared to controls. Scale bar, 10 mm.
(B) RT-PCR analysis showed LCA optic cups had high relative levels of the cryptic exon. Values are mean ± 2 3 SEM. n = 3.
(C) Representative images of immunostaining of cilia (Arl13, red; PCN, green) in optic cups at weeks 5, 9, and 13. Scale bar, 20 mm.
(D and E) Quantification of ciliation (D) and cilia length (E) in weeks 5, 9, and 13 optic cups, as determined by Arl13 and PCN staining. Values are mean ± 23 SEM.
n = 3 counts of 200 pericentrin-positive structures. Statistical significancewas determined using one-way ANOVAwith post hoc Tukey’s test, *p < 0.05, **p < 0.01,
***p < 0.001, n.s. = not significant.
(F) RT-PCR analysis of CEP290 splicing and retinal-specific exons (BBS8 2A and RPGRORF15) in control (Con) and CEP290-LCA optic cups at different times of
development. See also Figure S5.and that photoreceptor ONL thickness is normal in the cone-
rich fovea, but severely reduced toward the rod-rich peripheral
retina (Boye et al., 2014; Cideciyan et al., 2007; Pasadhika
et al., 2010). Indeed, our CEP290 patient has central photore-
ceptor preservation at over 40 years of age (Figure S1). This
suggests that the therapeutic window for CEP290-LCA caused
by this intronic change might be longer than previously esti-
mated and that photoreceptors might be more amenable to
gene-directed therapies aimed at correcting splicing such as
that described here, especially given that CEP290 is too big
for conventional AAV gene therapy (Allocca et al., 2008). Lenti-
virus has proven an effective vector system for large cDNAs776 Cell Stem Cell 18, 769–781, June 2, 2016such as CEP290 (Burnight et al., 2014). However, the observed
cytotoxicity following CEP290 overexpression in cultured fibro-
blasts suggests that significant improvements will be required
to translate this approach into a safe therapy for LCA. A recent
study has shown that intravitreal injection of oligonucleotides
can alter photoreceptor splicing (Ge´rard et al., 2015) and is
relatively safe. Vitravene, which is used to treat CMV retinitis,
was the first antisense therapeutic approved by the FDA (Mar-
wick, 1998), and modified oligonucleotides might be stable in
the vitreous with good accessibility to the photoreceptor cell
layer for several months (Murray et al., 2015). Our data suggest
that AON therapy, either as intravitreal injection or through viral
Figure 5. CEP290-MO Treatment Increases
Wild-Type CEP290 Transcript Levels, Re-
duces Cryptic Exon Expression, and Res-
cues Ciliation
(A–C) RT-PCR analyses of CEP290 exon 26-27
and quantification of bands in LCA cells: (A) fi-
broblasts, (B) RPE, and (C) optic cups. Values are
mean ± 2 3 SEM. Statistical significance was
determined using Student’s t test, *p < 0.05, **p <
0.01. n = 3 for each cell type.
(D–L) Representative images of cilia (Ac. tub.,
green; PCN, red; or Arl13, red; PCN, green) and
quantification of cilia incidence and length in pa-
tient cells: (D–F) fibroblasts, (G–I) RPE, and (J–L)
optic cups. Values are mean ± 23 SEM. Statistical
significancewas determined using Student’s t test,
*p < 0.05, **p < 0.01, ***p < 0.001. (E and F) n = 4
counts of at least 80 cells per treatment, (H and I)
n = 3 counts of at least 70 cells per treatment, and
(K and L) n = 5 counts of at least 400 pericentrin-
positive structures. (D–F) Scale bar, 20 mm (10 mm
in zoompanel); (G–I) scale bar, 10mm(1mm in zoom
panel); and (J–L) scale bar, 20 mm (1 mm in zoom
panel). See also Figures S4 and S6.delivery, could be a practical therapeutic option for treating
CEP290-LCA and restoring gene function. Furthermore, this
study highlights the value of using iPSC-derived cells to study
photoreceptor development and function, interrogate disease
mechanisms, and test potential therapies for human mutations
in a genomic context.
EXPERIMENTAL PROCEDURES
Reprogramming of Fibroblasts to iPSCs
Following informed consent, a skin biopsy was obtained from a male CEP290
individual. Control BJ and LP6 fibroblasts and iPSCs were produced and char-
acterized as previously described (Schwarz et al., 2015). The study followed
the tenets of the Declaration of Helsinki and was approved by the MoorfieldsCeand Whittington Hospitals’ local Research Ethics
Committees and the NRES Committee London
Riverside Ethics Committee (REC 12/LO/0489).
Fibroblasts were cultured from the skin biopsy
as previously described (Schwarz et al., 2015).
iPSCs were generated from fibroblasts using the
following integration-free episomal plasmids from
Addgene: pCXLE-hOCT3/4-shp53-F, pCXLE-
hUL, and pCXLE-hSK. Reprogramming protocol
was as previously described (Okita et al., 2011;
Schwarz et al., 2015). In total, 1 3 106 cells were
mixed with 1 mg of each plasmid in 100 ml Nucleo-
fector solution from a Cell Line Nucleofector kit
(Lonza) before electroporation via Amaxa Nucleo-
fector I device. Electroporated cells were plated on
0.2% gelatin-coated 10 cm2 plates and cultured in
fibroblast media (DMEM supplemented with 10%
fetal bovine serum [FBS], 1 mM nonessential
amino acids [NEAA], 1 mM GlutaMax, and 1%
penicillin/streptomycin [P/S; Life Technologies])
supplemented with 0.5 mM sodium butyrate. After
7 days the cells were replated at 2 3 105 cells per
well into aMatrigel (Corning)-coated six-well plate.
The next day, the media was changed to mTESR-
E8 media (Stem Cell Technologies) until iPSC col-onies appeared (approximately 25 days). Clonal iPSC lines were mechanically
isolated and maintained in mTESR-E8.
Differentiation of iPSCs to RPE and Optic Cups
For spontaneous differentiation of iPSCs into RPE, iPSCs were passaged
into T25 cell culture flasks and maintained in mTESR-E8 media for
10 days, before the media was exchanged for RPE differentiation media
(KnockOut DMEM supplemented with 20% KnockOut Serum Replacement
[KOSR], 1 mM NEAA, 1 mM GlutaMax [all Life Technologies], and 100 mM
b-mercaptoethanol) until pigmented colonies were formed. iPSC-RPE col-
onies were manually isolated using crescent blades as previously described
(Schwarz et al., 2015) before being plated at a density of 5 3 104 cells per
cm2 in X-VIVO-10 media (Scientific Laboratory Supplies). The media was
changed every 3–4 days until a pigmented monolayer had formed (approxi-
mately 6–8 weeks).ll Stem Cell 18, 769–781, June 2, 2016 777
Figure 6. CEP290-MO Rescues CEP290 Protein and the Cilia Traffic of RPGR and Rab8 in LCA Fibroblasts
(A) Representative images of control and LCA fibroblasts treated with control- or CEP290-MO and stained with CEP290 (green) and PCN (red). Arrowheads show
drastically reduced CEP290 basal body localization in LCA fibroblasts compared.
(B) Quantification of CEP290 immunofluorescence intensity at the basal body. Values are mean ± 2 3 SEM. n = 3 replicates of at least 30 cells. Statistical
significance was determined using one-way ANOVA with post hoc Tukey’s test, *p < 0.05, **p < 0.01, ***p < 0.001.
(C) Western blot showing increased level of CEP290 protein in LCA fibroblasts after CEP290-MO treatment.
(D and F) Representative images of (D) RPGR or (F) Rab8 (green) localization in the cilium in control or LCA fibroblasts. Ciliary axoneme is marked by acetylated
a-tubulin (Ac. tub.; red).
(E and G) Quantification of (E) RPGR or (G) Rab8 localization at the base of the cilia (upper) and fluorescence intensity in the axoneme (lower). Values are mean ±
23 SEM. n = 3 replicates of 50 cells. Statistical significance was determined using one-way ANOVAwith post hoc Tukey’s test, *p < 0.05, **p < 0.01, ***p < 0.001,
n.s. = not significant. Scale bar, 2 mm. See also Figure S6.Directed differentiation of iPSCs into 3D optic cups was based on the
protocol by Nakano et al. (Nakano et al., 2012). iPSCs were dissociated using
TrypLE (Life Technologies) and plated at a density of 9,000 per well in
V-shaped 96-well plates in EB media (GMEM supplemented with 20%
KOSR, 1 mM NEAA, 1 mM GlutaMax, 1 mM sodium pyruvate, and 100 mM
b-mercaptoethanol) supplemented with 20 mM Y-27632 (Millipore) and 3 mM
IWR1e (Calbiochem). After 48 hr (day 2) cells were topped up with EB media
containing 20 mM Y-27632, 3 mM IWR1e, and 2% Matrigel (EB2 media). EB2
media was exchanged every 2 days until day 12 when the EBs were trans-778 Cell Stem Cell 18, 769–781, June 2, 2016ferred to 25-well nonadherent dishes for further culture in EB media with
10% FBS, 1% Matrigel, 20 mM Y-27632, and 100 nM smoothened agonist
(SAG; Enzo Life Sciences). After 3 days (day 15) media was exchanged for
EB media with 10% FBS, 1% Matrigel, 20 mM Y-27632, 100 nM SAG, and
3 mM CHIR99021 (Tocris). Media was exchanged every 2 days until day 18
when EB media was exchanged for neural retinal differentiation (NR) media
(DMEM-F12 supplemented with 10% FBS, 13 N2 supplement [Life Technol-
ogies], and 0.5 mM retinoic acid [RA; Tocris]). Pouches of transparent neuro-
epithelium were manually isolated under a dissecting microscope at day 30
Figure 7. CEP290-MO Rescues CEP290 Protein and the Cilia Traffic of RPGR in LCA Optic Cups
(A) Representative images of control and LCA optic cups treated with control- or CEP290-MO and stained with CEP290 (green) and PCN (red). Arrows show
overlap of CEP290 with PCN in control- and CEP290-MO-treated LCA optic cups, respectively. Scale bar, 5 mm
(B and C) Quantification of (B) CEP290 immunofluorescence intensity and (C) CEP290 localization at the basal body. Values are mean ± 23 SEM. n = 3 replicates
of at least 45 cilia. Statistical significance was determined using one-way ANOVA with post hoc Tukey’s test, *p < 0.05, **p < 0.01, n.s. = not significant.
(D) Western blot showing increased level of CEP290 protein in LCA optic cups after CEP290-MO treatment.
(E and F) Representative images of (E) CEP290 or (F) RPGR (green) localization at the connecting cilium (CC) in control or LCA optic cups. Ciliary axoneme is
marked by polyglutamylated tubulin (GT335; red).
(G and H) Quantification of (G) CEP290 or (H) RPGR localization at the CC. Values are mean ± 2 3 SEM. n = 3 replicates of at least 50 cilia. Statistical
significance was determined using one-way ANOVAwith post hoc Tukey’s test, *p < 0.05, **p < 0.01, ***p < 0.001, n.s. = not significant. Scale bar, 2 mm. See also
Figure S7.and transferred to fresh 25-well nonadherent dishes. These were maintained
for up to 21 weeks, changing NR media every 3–4 days. Please see Supple-
mental Experimental Procedures for details of RNA extraction and RT-PCR,
electron microscopy, immunoblotting, immunofluorescence, and imaging of
cells.Morpholino Treatment
CEP290-specific antisense MO oligonucleotide was purchased from
GeneTools, with the sequence 50-GGATAGGTATGAGATACTCACAATT-30.
Standard control MO (50- CCTCTTACCTCAGTTACAATTTATA-30 ) was
also from GeneTools. MOs were diluted from a stock concentration of 1 mMCell Stem Cell 18, 769–781, June 2, 2016 779
to concentrations indicated in the text, in appropriate sterile culturemedia sup-
plemented with 6 mM EndoPorter (GeneTools).
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